cytarabine and xmd 8-92

cytarabine has been researched along with xmd 8-92 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Studzinski, GP; Zheng, R	1

Other Studies

1 other study(ies) available for cytarabine and xmd 8-92

Article	Year
Optimal AraC-Cytotoxicity to AML Cells Requires ERK5 Activity. Journal of cellular biochemistry, 2017, Volume: 118, Issue:6 Topics: Aniline Compounds; Antimetabolites, Antineoplastic; Benzodiazepinones; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Cytarabine; Gene Expression Regulation, Leukemic; HL-60 Cells; Humans; Indoles; Leukemia, Myeloid, Acute; Mitogen-Activated Protein Kinase 7; Phosphorylation; Proto-Oncogene Proteins c-bcl-2	2017

Article

Year

Optimal AraC-Cytotoxicity to AML Cells Requires ERK5 Activity.

Journal of cellular biochemistry, 2017, Volume: 118, Issue:6

Topics: Aniline Compounds; Antimetabolites, Antineoplastic; Benzodiazepinones; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Cytarabine; Gene Expression Regulation, Leukemic; HL-60 Cells; Humans; Indoles; Leukemia, Myeloid, Acute; Mitogen-Activated Protein Kinase 7; Phosphorylation; Proto-Oncogene Proteins c-bcl-2

2017